跳至主要内容
临床试验/NCT05390632
NCT05390632招募中不适用

Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas

Peking University Cancer Hospital & Institute1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
SUVmax

研究概览

简要总结

Investigating the performance of 18F-FDG PET/CT and PET/MRI in lymphomas

详细描述

In this study investigators evaluated Nodal and Extranodal Lymphoma Lesions uptake by 18F-FDG PET (PET/CT and PET/MR). Prior to treatment, all patients will undergo whole-body 18F-FDG PET/CT and PET/MR. The methods' efficiency was compared in the diagnosis of lymph node (LN) and organ involvement.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
15 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pathologically diagnosed as lymphoma; Written informed consent for receiving PET/MRI after PET/CT examinations. cancer planned chemotherapy or immunotherapy scheme. expected survival ≥ 12 weeks

排除标准

  • cannot lie supine for half an hour; refuse to join the clinical researcher; severe liver or kidney dysfunction pregnancy or lactation

结局指标

主要结局

SUVmax

时间窗: 150 days

Standardized uptake value of 18F-FDG PET/CT and PET/MRI for target lesion of subject or suspected tumor in each time point window (SUV)

次要结局

未报告次要终点

研究者

发起方
Peking University Cancer Hospital & Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xuejuan Wang

Principal Investigator

Peking University Cancer Hospital & Institute

研究点 (1)

Loading locations...

相似试验